Literature DB >> 26481013

[Party and designer drugs : From ecstasy and crystal meth to angel's trumpet].

F Erbguth1.   

Abstract

BACKGROUND: The growing abuse of party and designer drugs increases the number of emergency cases related to drug consumption.
OBJECTIVES: Presentation of the scenario as well as the diagnostic and therapeutic principles of emergency management and characterization of the most frequently abused drugs and its effects.
MATERIALS AND METHODS: Evaluation of drug statistics, and work-up and discussion of expert publications and recommendations.
RESULTS: In 2014, there were 1032 drug-related deaths, which is 3 % more incidents than in 2013. However, there is a drastically and steadily increasing consumption of newer enhancing drugs such as crystal meth. Throughout Europe, there are about 1500 designer drugs that are disguised as so-called spice mixtures or bath salts. In addition to stimulating substances, hallucinogenic and sedative drugs are also consumed. Common nonspecific symptoms of emergency drug overdose are psychosis, impaired consciousness, seizures, and disorders of various internal organs. Based on the clinical presentation, different neurotransmitter syndromes can be distinguished and the drug etiology can be diagnosed and proven by laboratory assays. Therapy includes symptom-oriented measures.
CONCLUSIONS: Knowledge of different party and designer drugs and their complications enables prompt emergency management.

Entities:  

Keywords:  Crack cocaine; Drug overdose; Drug-related side effects and adverse reactions; Emergencies; Street drugs

Mesh:

Substances:

Year:  2015        PMID: 26481013     DOI: 10.1007/s00063-015-0098-8

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  30 in total

1.  Designer drugs in the general hospital.

Authors:  Philip A Bialer
Journal:  Psychiatr Clin North Am       Date:  2002-03

Review 2.  Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.

Authors:  Fridtjof Heyerdahl; Knut Erik Hovda; Isabelle Giraudon; Christopher Yates; Alison M Dines; Roumen Sedefov; David M Wood; Paul I Dargan
Journal:  Clin Toxicol (Phila)       Date:  2014-10-31       Impact factor: 4.467

Review 3.  Management of drug and alcohol withdrawal.

Authors:  Thomas R Kosten; Patrick G O'Connor
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

4.  A young man with hemiplegia after inhaling the bath salt "Ivory wave".

Authors:  K Boshuisen; J E Arends; D R Rutgers; C J M Frijns
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

5.  The changing face of teenage drug abuse--the trend toward prescription drugs.

Authors:  Richard A Friedman
Journal:  N Engl J Med       Date:  2006-04-06       Impact factor: 91.245

Review 6.  Cannabis and stroke: systematic appraisal of case reports.

Authors:  Daniel G Hackam
Journal:  Stroke       Date:  2015-03       Impact factor: 7.914

7.  Body packer: cocaine intoxication, causing death, masked by concomitant administration of major tranquilizers.

Authors:  C Klein; Y Balash; L Pollak; J Hiss; M J Rabey
Journal:  Eur J Neurol       Date:  2000-09       Impact factor: 6.089

8.  The neurovascular complications of cocaine.

Authors:  R D Fessler; C M Esshaki; R C Stankewitz; R R Johnson; F G Diaz
Journal:  Surg Neurol       Date:  1997-04

Review 9.  Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases.

Authors:  S K Aggarwal; V Williams; S R Levine; B J Cassin; J H Garcia
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

10.  A fatal case of spongiform leukoencephalopathy linked to "chasing the dragon".

Authors:  Heather Long; Kimberly Deore; Robert S Hoffman; Lewis S Nelson
Journal:  J Toxicol Clin Toxicol       Date:  2003
View more
  1 in total

1.  [Mother and son between omnipotence and coma].

Authors:  J Heyckendorf; S Brede; X Guo; B Haberl; F Sayk
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-12-20       Impact factor: 0.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.